Trial Profile
Cardiovascular Effects of Combined Administration of Siponimod and Propranolol - Importance of Sequencing During Co -administration
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Dec 2017
Price :
$35
*
At a glance
- Drugs Siponimod (Primary) ; Propranolol
- Indications Cardiovascular disorders; Multiple sclerosis
- Focus Pharmacodynamics
- Sponsors Novartis Pharma A.G.
- 29 Apr 2014 Results presented at the 66th Annual Meeting of the American Academy of Neurology.
- 29 Apr 2014 Results presented at the 66th Annual Meeting of the American Academy of Neurology.
- 24 Apr 2014 New trial record